Sumitomo Pharma Co (TSE:4506) Inventories, Raw Materials & Components: 円0 Mil (As of Mar. 2026)


TSE:4506 Sumitomo Pharma Co Ltd TSE:4506
56 GF Score
Price 円1,557.00
GF Value 円831.86
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sumitomo Pharma Co Inventories, Raw Materials & Components?

Sumitomo Pharma Co TSE:4506 +4.50% 56 Inventories, Raw Materials & Components is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4506 with a GF Score™ of 56/100 and a GF Value™ of 円831.86 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Sumitomo Pharma Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was 円0 Mil.

Sumitomo Pharma Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Sumitomo Pharma Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co Inventories, Raw Materials & Components Chart

Sumitomo Pharma Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sumitomo Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4506
56GF Score
Sumitomo Pharma Co Ltd TSE:4506
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sumitomo Pharma Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of 円0 Mil mean?
Sumitomo Pharma Co (TSE:4506) has a Inventories, Raw Materials & Components of 円0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Sumitomo Pharma Co and its competitors.
Is Sumitomo Pharma Co's Inventories, Raw Materials & Components too high?
Sumitomo Pharma Co's current Inventories, Raw Materials & Components is 円0 Mil. Overall, Sumitomo Pharma Co has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sumitomo Pharma Co's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Sumitomo Pharma Co's Inventories, Raw Materials & Components of 円0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Sumitomo Pharma Co and its competitors. Sumitomo Pharma Co's current Inventories, Raw Materials & Components is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sumitomo Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Sumitomo Pharma Co (TSE:4506) is currently considered Significantly Overvalued. The stock's GF Value™ is 円831.86, compared to a current price of 円1,557.00 — trading 87.2% above its estimated fair value. The current Inventories, Raw Materials & Components is 円0 Mil. Sumitomo Pharma Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Sumitomo Pharma Co (TSE:4506), the current Inventories, Raw Materials & Components is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sumitomo Pharma Co (TSE:4506) Overvalued in 2026?

Based on GuruFocus' analysis, Sumitomo Pharma Co stock appears to be overvalued. The current stock price of 円1,557.00 is trading 87.2% above its estimated GF Value™ of 円831.86. GuruFocus considers Sumitomo Pharma Co to be Significantly Overvalued.

Key valuation signals for TSE:4506:

  • Inventories, Raw Materials & Components: 円0 Mil
  • GF Value™: 円831.86 vs. price of 円1,557.00 (87.2% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the TSE:4506 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sumitomo Pharma Co Business Description

Address 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
56GF Score

Get the complete analysis for TSE:4506

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,557.00
Price
円831.86
GF Value